Amyloid PET Variability due to Variation in MRI Protocol and Anatomical Segmentation
The comments were made during the following Q&A session with Paul Stevens from BGF’s investment fund, who focuses on identifying opportunities among AIM-listed companies: 1. Can you provide some background on BGF and the sectors/types of companies you invest in?BGF was set up in 2011 to help support small growing companies in the UK.
Classifying cognitively healthy subjects from mild cognitive impaired and Alzheimer's disease patients using Tau-PET: The role of spatial resolution and PET pre-processing
A fully automatic pipeline for estimation of regional brain volume change using Jacobian integration
A pipeline for automated diffusion MRI analysis: overview and application to the study of Alzheimer’s Disease
A Fully Automatic Pipeline for Estimation of Putamen and Caudate Volume
73-80 of 142 results